Cyfra 21-1: A serological help for detection of distant metastases in head and neck cancer

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 2241-2243

  Maass, Jan D ^a   Hoffmann Fazel, Asita ^a   Goeroegh, Tibor ^a   Hoffmann, Markus ^a   Meyer, Jens E ^a   Gottschlich, Stefan ^a   Rudert, Heinrich ^a   Maune, Steffen ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Cyfra 21 1; Distant metastases; Head and neck; Tumor marker

Indexed keywords

CYTOKERATIN 19 FRAGMENT; TUMOR MARKER;

ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL TRIAL; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; SERODIAGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; KERATINS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 0033883419     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Pastor A, Menendez R, Cremades MJ, Pastor V, Llopis R and Aznar J: Diagnostic value of/SCC, CEA and Cyfra 21-1 in lung cancer: a Bayesian analysis. Eur Respir J 10: 603-609, 1997.
2. Yamamoto K, Oka M, Hayashi H, Tangoku A, Gondo T and Suzuki T: Cyfra 21-1 is a useful, marker for esophageal squamous cell carcinoma. Cancer 79: 1647-55, 1997.
3. Nagler RM, Barak M, Peled M, Ben-Aryeh H, Filatov M and Laufer D: Early diagnosis and treatment monitoring rules of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 85: 1018-25, 1999.
4. Bodenmuller H, Banauch D, Ofenloch B, Jaworek D and Dessauer A: Technical evaluation of a new automated tumor marker assay: The Enzymun-Test CYFRA 21-1. In: Klapdor, R (ed.) Tumor associated antigens, oncogens, receptors, cytokines in tumor diagnosis and therapy at the beginning ofthe nineties. Munich: Zuckschwerdt: 137-138, 1992.
5. Niemann AM, Gorogh T, Gottschlich S, Lippert BM and Werner JA: Cut-off value determination of Cyfra 21-1 for squamous cell carcinoma ofthe head and neck (SCCHN). Anticancer Res 17: 2859-2860, 1997.
6. Stieber P, Dienemann H, Hasholzner U, Muller Ch, Poley S, Hofmann K and Fateh-Moghadam A: Comparison of cytokeratin fragment 19 (Cyfra 21-1), tissue polypeptide antigen (TPS) as tumor markers in lung cancer. Eur J Clin Chem Clin Biochetn 31: 689-694, 1993.
7. Molina R, Augusti C, Filella X, Jo J, Joseph J, Gimenez N and Ballesta A: Study of a new tumor marker, Cyfra 21-1, in malignant and non-malignant diseases. Tumor Biol 15: 318-325, 1994.
8. Niklinski J, Furman M, Chyczewska E, Chyczewska L, Rogowski F, Jaroszewicz E and Laudanski J: Evaluation of Cyfra 21-1 as a new marker for non-small cell lung cancer. Eur J Cancer Prev 3: 227-230, 1994.
9. Sugama Y, Kitamura S, Kawai T, Ohkuho A, Hasegawa S, Kuriyama T, Kato H, Fukuoka M, Ohkawa J: Clinical usefulness of Cyfra assay in diagnosing lung cancer: Measurement of serum cytokeratin fragment. Jpn J Cancer Res 85: 1178-1184, 1994.
10. Rapellino M, Niklinski J, Pecchio F, Furman M, Baldi S, Chyczewski L, Ruffini E and Chyczewski E: Cyfra 21-1 as a tumor marker for bronchogenic carcinoma. Eur Respir J 8: 407-410, 1995.
11. Nakamura T, Ide H, Eguchi R, Hayashi K, Takasaki K and Watanabe S: Cyfra 21-1 as a tumor marker of the esophagus. Dis Esophagus 11: 35-39, 1998.
12. Callet N, Cohen-Soial Le Nir CC, Berthelot E and Pichon MF: Cancer of the uterine cervix: sensitivity and specificity of serum Cyfra 21-1 determinations. Eur J Gynaecol Oncol 19: 50-56, 1998.
13. Wollenberg B, Jan V, Schmit UM, Hofmann K, Stieher P and Fateh-Moghadam A: Cyfra 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer. Anticancer Res 16: 3117-3124, 1997.
14. Yen TC, Lin WC, Kao CH, Cheng KY and Wang SJ: A study of a new tumor marker, Cyfra 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen. Clin Otolaryngol 23: 82-86, 1998.
15. Niemann AM, Paulsen JI, Lippert BM, Henze E, Gorogh T, Gottschlich S and Wemer JA: Cyfra 21-1 in patients with head and neck cancer. In: JA Wemer, BM Lippert, HH Rudert (Eds.) Head and neck cancer: Advances in basic research. Elsevier, Amsterdam: 529-537, 1996.